Acceleron Pharma competitors

Acceleron Pharma Competitors include Novartis, Bristol-Myers Squibb, AstraZeneca and Moderna Therapeutics.
Add company...
Acceleron Pharma
Acceleron Pharma
Acceleron Pharma is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Novartis
Novartis
Novartis researches, develops, manufactures, and markets a range of healthcare products.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
AstraZeneca
AstraZeneca
AstraZeneca, a global pharmaceutical company, discovers, develops, manufactures and markets prescription medicines.
Moderna Therapeutics
Moderna Therapeutics
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Founding Date
Founding Date
2003
Founding Date
1996
Founding Date
1887
Founding Date
1999
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Basel, CH HQ
Núñez, AR
Elsene, BE
São Paulo, BR
Dorval, CA
Chaoyang Qu, CN
Praha 4, CZ
see more
Locations
New York, US HQ
Vienna, AT
Braine L'alleud, BE
Calgary, CA
Edmonton, CA
Montreal, CA
Toronto, CA
see more
Locations
Cambridge, GB HQ
Sydney, AU
Brussels, BE
Fredericton, CA
Hamilton, CA
Mississauga, CA
Montreal, CA
see more
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Cambridge, US
Norwood, US
Chicago, US
Huntington, US
Employees
Employees
17324% increase
Employees
126,0004% increase
Employees
23,700
Employees
61,100
Employees
6801% increase
Valuation ($)
Valuation ($)
2.3 b
Valuation ($)
175.5 b
Valuation ($)
78.6 b
Valuation ($)
107.9 b
Valuation ($)
6.3 b
Twitter followers
Twitter followers
499
Twitter followers
234.4 k
Twitter followers
120.8 k
Twitter followers
141.3 k
Twitter followers
2.4 k

Financial

Revenue (est.)
Revenue (est.)
$14m (FY, 2018)
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
$22.6b (FY, 2018)
Revenue (est.)
£22.5b (FY, 2017)
Revenue (est.)
$205.8m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$17.2b (FY, 2017)
Cost of goods
N/A
Cost of goods
£4.3b (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$31.9b (FY, 2017)
Gross profit
N/A
Gross profit
£18.1b (FY, 2017)
Gross profit
N/A
Net income
Net income
($118.9m) (FY, 2018)
Net income
$7.7b (FY, 2017)
Net income
$4.9b (FY, 2018)
Net income
£2.9b (FY, 2017)
Net income
($255.9m) (FY, 2017)

Operating

Phase III Trials Products
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
29 (Y, 2016)
Phase III Trials Products
8 (FY, 2016)
Phase III Trials Products
27 (FY, 2016)
Phase III Trials Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
132 (FY, 2016)
Projects in R&D Pipeline
N/A

Funding

Total funding raised
Total funding raised
$ 141.8m
Total funding raised
$ 6.5m
Total funding raised
$ 15.5m
Total funding raised
N/A
Total funding raised
$ 1.7b
For sources of this data, please see the company profileDownload Excel

View company profiles

Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase

Novartis researches, develops, manufactures, and markets a range of healthcare products.

View company
Bristol-Myers Squibb
HQ
New York, US
Employees
23,700

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

View company
AstraZeneca
HQ
Cambridge, GB
Employees
61,100

AstraZeneca, a global pharmaceutical company, discovers, develops, manufactures and markets prescription medicines.

View company
Moderna Therapeutics
HQ
Cambridge, US
Employees
680↑ 1% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company